Babesia divergens vaccine.

Area of Science:

• Veterinary Parasitology
• Immunology
• Vaccine Development

Background:

• Bovine babesiosis, caused by Babesia divergens, poses a significant threat to cattle health and productivity worldwide.
• Effective vaccines are crucial for controlling parasitic diseases in livestock.
• Previous vaccine strategies have faced challenges in efficacy and scalability.

Purpose of the Study:

• To develop and evaluate a novel vaccine strategy against Babesia divergens bovine babesiosis.
• To assess the protective efficacy of crude supernatants and purified fractions in animal models.
• To identify key Babesia divergens exoantigens involved in inducing protective immunity.

Main Methods:

• Development of an efficient in vitro culture system for Babesia divergens.
• Preparation of crude supernatants and purified fractions from cultured parasites.
• Vaccination of gerbils and cattle with the prepared antigens.
• Challenge studies to evaluate vaccine-induced protection against Babesia divergens infection.
• Analysis of the role of specific exoantigens (17, 37, 46, 70, 90 kDa) in immune response.

Main Results:

• Successful development of an efficient in vitro culture for Babesia divergens.
• Crude supernatants and purified fractions induced significant vaccine protection in gerbils against B. divergens infection.
• Supernatants also demonstrated effective vaccine protection in cattle.
• The involvement of 17, 37, 46, 70, and 90 kDa exoantigens in the immune response was confirmed across gerbils, cattle, and humans.

Conclusions:

• An effective vaccine strategy against Babesia divergens bovine babesiosis has been developed.
• The study highlights the potential of exoantigens from in vitro cultured Babesia divergens as vaccine components.
• The findings provide a foundation for further development of subunit vaccines against bovine babesiosis.